Shiga-like toxin subunit B (SLTB)-enhanced delivery of chlorin e6 (Ce6) improves cell killing

Photochemistry and Photobiology
Maria Teresa Tarragó-TraniBrian Storrie

Abstract

We used Shiga-like toxin B subunit (SLTB) to deliver the photosensitizer, chlorin e6 (Ce6), to Vero cells expressing the Gb3 receptor. Our aim was to provide an example of carrier-enhanced photodynamic cell killing with which to start a systematic consideration of photosensitizer delivery at the subcellular level. SLTB, in contrast to many other potential protein carriers, is delivered intracellularly to the Golgi apparatus and endoplasmic reticulum (ER). Ce6 was chosen both for its phototoxic properties and its potential for covalent conjugation with SLTB. Ce6-SLTB after cleanup contained < or =10% noncovalently bound Ce6. The noncovalent binding of porphyrins and chlorins to protein conjugates has been well documented, and hence the effective cleanup procedure is a significant accomplishment. We demonstrate that Ce6-SLTB enhances delivery of Ce6 to target cells as compared to free Ce6. In Vero cells, Ce6-SLTB was over an order of magnitude more photodynamically toxic than free Ce6. Moreover, we show that in the case of Ce6-SLTB, photosensitizer accumulation is in a combination of subcellular sites including mitochondria, Golgi apparatus, ER and plasma membrane. The occurrence in nature of diverse B subunit binding sites and t...Continue Reading

References

Feb 15, 1990·Analytical Biochemistry·Z Grabarek, J Gergely
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A R OseroffM L Yarmush
Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·H Farkas-HimsleyC A Lingwood
Jan 1, 1994·Nature Structural Biology·M E FraserM N James
Apr 28, 1997·Toxicology Letters·J M WilliamsC M Taylor
Aug 1, 1997·The Journal of Biological Chemistry·L JohannesB Goud
Aug 15, 1997·The Journal of Biological Chemistry·T V AkhlyninaA S Sobolev
May 21, 1999·Archives of Biochemistry and Biophysics·T G GantchevJ E van Lier
Oct 26, 1999·Drug Discovery Today·W M Sharman van Lier JE
Feb 15, 2000·Journal of Photochemistry and Photobiology. B, Biology·B CunderlíkováJ Moan
Oct 25, 2000·Photochemistry and Photobiology·M R HamblinB Ortel
Jun 22, 2001·Critical Reviews in Oncology/hematology·J Gariépy
Oct 12, 2001·Toxicon : Official Journal of the International Society on Toxinology·K Sandvig
Feb 21, 2002·Infection and Immunity·Paola MarcatoGlen D Armstrong
Jul 27, 2002·Annual Review of Cell and Developmental Biology·Kirsten Sandvig, Bo van Deurs
Aug 6, 2003·Biochemistry·David G PinaValery L Shnyrov
Jan 7, 2004·Advanced Drug Delivery Reviews·Wesley M SharmanCynthia M Allen
Mar 5, 2004·Biotechnology & Genetic Engineering Reviews·Lily TongKevin J Yarema
Nov 24, 2004·Protein Expression and Purification·Maria Teresa Tarragó-Trani, Brian Storrie
Jan 25, 2005·Journal of Photochemistry and Photobiology. B, Biology·John WebberDavid Kessel
Mar 1, 2005·Toxicon : Official Journal of the International Society on Toxinology·David G Pina, Ludger Johannes
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark D Savellano, Tayyaba Hasan
Apr 9, 2005·Gene Therapy·K Sandvig, B van Deurs
Apr 15, 2005·Molecular Biology of the Cell·Rebecca S MaagCarolyn E Machamer
May 5, 2005·DNA and Cell Biology·Mark Richter, Hongtao Zhang

❮ Previous
Next ❯

Citations

Dec 22, 2009·Nature Reviews. Microbiology·Ludger Johannes, Winfried Römer
Nov 12, 2014·Biochemistry. Biokhimii︠a︡·A A RosenkranzA S Sobolev
Jul 10, 2013·International Journal of Pharmaceutics·Hye Myeong LeeDae Hwan Kang
Nov 4, 2008·Expert Opinion on Drug Delivery·Stéphane A SibaniRyan F Donnelly
Jun 24, 2008·Annales pharmaceutiques françaises·P PrognonP Maillard
Feb 21, 2013·Clinical Endoscopy·Il YoonYoung Key Shim
Jan 25, 2011·Microbial Biotechnology·Nikolai EngedalKirsten Sandvig
Jul 30, 2015·Biochemical and Biophysical Research Communications·Jeong-Hyun RyouHak-Sung Kim
Sep 11, 2012·Toxicon : Official Journal of the International Society on Toxinology·Jonas BerganKirsten Sandvig
Apr 27, 2017·Macromolecular Bioscience·Claudia Battistella, Harm-Anton Klok
Sep 17, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hui Shan LiewMay Lee Low

❮ Previous
Next ❯

Software Mentioned

Image J
IPLab

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.